Integrin alpha-5/beta-1 inhibitor (Pliant Therapeutics/UCSF)

N/A

Report date: 2025/03/20 16:03:57

Base Information

Drug NameIntegrin alpha-5/beta-1 inhibitor (Pliant Therapeutics/UCSF)
Drug Alias NameN/A
ClassificationOther
Mechanisms of ActionIntegrin alpha-5/beta-1 inhibitorsIntegrin alpha-M antagonists
TargetsIntegrin alpha-5/beta-1Integrin alpha-M
Therapy Area/IndicationsAsthma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesPliant Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesPliant Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsAsthma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A